SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4

Eduard Dolušić; Laurent De Backer; Stéphane Collin; Steve Lanners

SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4

Eduard Dolušić, Laurent De Backer, Stéphane Collin, Steve Lanners

Research output: Contribution to conference › Poster

32 Downloads (Pure)

Abstract

Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretum caffrum. It is endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity. [1-2] As such, 1 has a strong potential in the anticancer therapy, prompting the development of new derivatives. [3-6] We have turned our attention to the design of a synthetic procedure for 1 performed entirely in
flow, which should enable continuous and rapid production of this useful compound and its derivatives in significant quantities.
Presented in this poster is a crucial step in this synthetic strategy - a selective semi-reduction of the triple bond of an alkyne precursor to the Z-double bond in the final product. The Lindlar-type hydrogenation in flow has been described only scarcely and for products typically more stable than Z-stilbenes. [7] We therefore set out to explore this technique and decided to expand it to a wider range of structurally various alkynes.

Original language	English
Pages	Book of Abstracts, 14th Belgian Organic Synthesis Symposium, P087, p. 136
Number of pages	1
Publication status	Published - 13 Jul 2014
Event	BOSS XIV - 14th Belgian Organic Synthesis Symposium - Aula Magna, Louvain-la-Neuve, Belgium Duration: 13 Jul 2014 → 18 Jul 2014

Conference

Conference	BOSS XIV - 14th Belgian Organic Synthesis Symposium
Country	Belgium
City	Louvain-la-Neuve
Period	13/07/14 → 18/07/14

Access to Document

Dolusic poster LLN 2014Final published version, 2.32 MB

Fingerprint Dive into the research topics of 'SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4'. Together they form a unique fingerprint.

Projects

1 Finished

MICROECO: RW-Développement d'un procédé microfluide continu, à empreinte écologique minimale, pour la production de peroxyde d'hydrogène par synthèse directe

LANNERS, S. & Dolušić, E.

1/02/13 → 1/02/17

Project: Research

Equipment

Physical Chemistry and characterization(PC2)

Johan Wouters (Manager) & Carmela Aprile (Manager)

Technological Platform Physical Chemistry and characterization

Facility/equipment: Technological Platform

Activities

3 Participation in conference
2 Participation to a Symposium, a study Day

BOSS XIV - 14th Belgian Organic Synthesis Symposium

Eduard Dolusic (Poster)

13 Jul 2014 → 18 Jul 2014

Activity: Participating in or organising an event types › Participation in conference

Balticum Organicum Syntheticum 2014

Eduard Dolusic (Poster)

6 Jul 2014 → 9 Jul 2014

Activity: Participating in or organising an event types › Participation in conference

Microfluidics: Fundamentals and Applications - BePCIS symposium

Eduard Dolusic (Participant)

8 May 2014

Activity: Participating in or organising an event types › Participation to a Symposium, a study Day

Cite this

Dolušić, E., De Backer, L., Collin, S., & Lanners, S. (2014). SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4. Book of Abstracts, 14th Belgian Organic Synthesis Symposium, P087, p. 136. Poster session presented at BOSS XIV - 14th Belgian Organic Synthesis Symposium, Louvain-la-Neuve, Belgium.

@conference{2b280df6726142abb53e22cc0ae531f3,

title = "SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4",

abstract = "Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretum caffrum. It is endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity. [1-2] As such, 1 has a strong potential in the anticancer therapy, prompting the development of new derivatives. [3-6] We have turned our attention to the design of a synthetic procedure for 1 performed entirely inflow, which should enable continuous and rapid production of this useful compound and its derivatives in significant quantities.Presented in this poster is a crucial step in this synthetic strategy - a selective semi-reduction of the triple bond of an alkyne precursor to the Z-double bond in the final product. The Lindlar-type hydrogenation in flow has been described only scarcely and for products typically more stable than Z-stilbenes. [7] We therefore set out to explore this technique and decided to expand it to a wider range of structurally various alkynes.",

author = "Eduard Dolu{\v s}i{\'c} and {De Backer}, Laurent and St{\'e}phane Collin and Steve Lanners",

year = "2014",

month = jul,

day = "13",

language = "English",

pages = "Book of Abstracts, 14th Belgian Organic Synthesis Symposium, P087, p. 136",

note = "BOSS XIV - 14th Belgian Organic Synthesis Symposium ; Conference date: 13-07-2014 Through 18-07-2014",

}

SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4. / Dolušić, Eduard; De Backer, Laurent; Collin, Stéphane ; Lanners, Steve.

2014. Book of Abstracts, 14th Belgian Organic Synthesis Symposium, P087, p. 136 Poster session presented at BOSS XIV - 14th Belgian Organic Synthesis Symposium, Louvain-la-Neuve, Belgium.

Research output: Contribution to conference › Poster

TY - CONF

T1 - SELECTIVE SEMIREDUCTION OF ALKYNES AS PART OF AN ENVISAGED CONTINUOUS FLOW SYNTHESIS OF COMBRETASTATIN A-4

AU - Dolušić, Eduard

AU - De Backer, Laurent

AU - Collin, Stéphane

AU - Lanners, Steve

PY - 2014/7/13

Y1 - 2014/7/13

N2 - Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretum caffrum. It is endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity. [1-2] As such, 1 has a strong potential in the anticancer therapy, prompting the development of new derivatives. [3-6] We have turned our attention to the design of a synthetic procedure for 1 performed entirely inflow, which should enable continuous and rapid production of this useful compound and its derivatives in significant quantities.Presented in this poster is a crucial step in this synthetic strategy - a selective semi-reduction of the triple bond of an alkyne precursor to the Z-double bond in the final product. The Lindlar-type hydrogenation in flow has been described only scarcely and for products typically more stable than Z-stilbenes. [7] We therefore set out to explore this technique and decided to expand it to a wider range of structurally various alkynes.

AB - Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretum caffrum. It is endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity. [1-2] As such, 1 has a strong potential in the anticancer therapy, prompting the development of new derivatives. [3-6] We have turned our attention to the design of a synthetic procedure for 1 performed entirely inflow, which should enable continuous and rapid production of this useful compound and its derivatives in significant quantities.Presented in this poster is a crucial step in this synthetic strategy - a selective semi-reduction of the triple bond of an alkyne precursor to the Z-double bond in the final product. The Lindlar-type hydrogenation in flow has been described only scarcely and for products typically more stable than Z-stilbenes. [7] We therefore set out to explore this technique and decided to expand it to a wider range of structurally various alkynes.

M3 - Poster

SP - Book of Abstracts, 14th Belgian Organic Synthesis Symposium, P087, p. 136

T2 - BOSS XIV - 14th Belgian Organic Synthesis Symposium

Y2 - 13 July 2014 through 18 July 2014

ER -